esophageal cancer. Malignant neoplasm of oesophagus
Conditions
Interventions
Intervention 1: the control group did not receivied the corton. Intervention 2: The intervention group received 125mg methylprednisolone sodium succinate.
Treatment - Drugs
the control group did not receivied the corton
The intervention group received 125mg methylprednisolone sodium succinate
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: esophageal cancer; indication for transhiatal esophagectomy; not using corticosteroids; tending to participate in the study exclusion criteria: change in surgery program; use of cortons before surgery; need neoadjuvant therapy; three hole esophagectomy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory complications. Timepoint: 2nd and 7th days after surgery. Method of measurement: blood factors (cc). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr. Reza Bagheri
mashshad university of medical sciences
Outcome results
None listed